资讯
2 天
MedPage Today on MSNInflammatory Markers Linked to Severe Attacks in Moderate AsthmaInflammatory markers boosted asthma attack prediction, potentially allowing intensification of treatment, according to a meta ...
Patients with severe asthma report fatigue, sleep disturbances, physical inactivity, and reduced work productivity as some of ...
A 72-year-old Chinese man was hospitalised after drinking excess water, triggering the worst asthma attack, making him unable ...
Patients with severe asthma initiated dupilumab and tezepelumab treatment more often than other biologics between 2022 and ...
23 小时on MSN
Rümeysa Öztürk said she has experienced several asthma attacks while in custody at a Louisiana facility, and had her hijab ...
Severe asthma is a chronic respiratory condition in which your symptoms are more intense and difficult to control than mild-to-moderate cases. Treatments include corticosteroids, biologics ...
Inflammatory markers play a pivotal role in phenotyping asthma, assessing risks, and tailoring personalised therapeutic strategies, particularly in asthma associated with allergic sensitisation ...
A new study published in the journal of Respiratory Investigation showed that in actual clinical practice, starting a ...
Patients with severe asthma required fewer steroid bursts with tezepelumab-ekko, according to a poster presented at the 2025 American Academy of Allergy, Asthma & Immunology/World Allergy Organization ...
AstraZeneca's first-in-class severe asthma therapy Tezspire has been approved in the EU in a new pen injector formulation suitable for administration by patients themselves. The green light for ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果